Sonoma Pharmaceuticals, Inc. (SNOA)
2.13
+0.03
(+1.43%)
USD |
NASDAQ |
Mar 27, 16:00
2.11
-0.02
(-0.94%)
After-Hours: 20:00
Sonoma Pharmaceuticals EPS Diluted (Quarterly) : -0.4781 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.819M |
| Revenue (Quarterly) | 4.349M |
| Total Expenses (Quarterly) | 5.168M |
| Enterprise Value | 1.780M |
| Gross Profit Margin (Quarterly) | 37.94% |
| Profit Margin (Quarterly) | -18.83% |
| Earnings Yield | -95.68% |
| Normalized Earnings Yield | -95.69 |